LanzaTech SPAC Presentation Deck

Leading Synbio Company Transforming Waste to Products LanzaTech's Differentiated Platform Allows it to Use Multiple Non-Food Feedstocks LanzaTech novozymes amyris Market Cap¹ $18.0B $1.6B GINKGO BIOWORKS™ $6.4B THE ORGANISM COMPANY Z zymergen* $0.4B Product Identification CO₂ Steel and MSW Refinery Biomass CO₂ Biogas Sugar Ferroalloy Gas Gas LanzaTech Microbe Design Commercial Operations ✓ X 2 Feedstock Capability MY m WY CO₂ 1 2 3 4 Why LanzaTech Differentiated End-to-End Capability Enables Expansion to Sustainable Materials Using Already-sourced Carbon Compatible With Installed Commercial Gas Fermentation Infrastructure Successful, At-Scale Piloting of First Key Molecules Complete with Hundreds Under Development Source: LanzaTech management, Capital IQ, Bloomberg; ¹ market data as of 02-Mar-2022, 2 Via their ownership/ relationship with Genomatica. 26

View entire presentation